We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

Data Sharing and Secondary Use of Data

What Can Stakeholders Expect from Clinical Trial (Development), Transparency and Medical Information?

Day & Time:
April 18, 2:00PM - 3:15PM (Central Europe Standard Time)

Session Number:

Room Number:
Boston 1-2


Data Sharing and Secondary Use of Data

Merete Joergensen, MBA, MSc
Senior Trial Disclosure Director, Global Clinical Registry
Novo Nordisk A/S, Denmark

Transparency of clinical information and sharing of person level data has been increasing over the last couple of years. Views of the challenges as well as the benefits experienced will be shared. The aim of the session is to share views on how to make the best out of the efforts that are put into sharing the wealth of information.

Presentation(s) & Speaker(s):
Aligning Clinical Trial Transparency Operations with Clinical Development Programme
Oladayo Oyelola, PhD
Director, Clinical Trial Information Disclosure
Daiichi Sankyo, Inc., United States

Experience in Sharing Clinical Data for Secondary Use
Martin Schumacher
Professor, Institute for Medical Biometry and Statistics
University of Freiburg, Germany

Sharing of Individual Patient Data (IPD) – Data Utility Considerations
Ingeborg Cil, MSc
Lead, Clinical Trial Data Anonymization
Shire, Austria